REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640200. A total of 29 filers reported holding REXAHN PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $7,000 | -56.2% | 14,100 | -18.5% | 0.00% | – |
| Q4 2018 | $16,000 | -62.8% | 17,300 | -28.8% | 0.00% | – |
| Q3 2018 | $43,000 | +10.3% | 24,300 | -13.2% | 0.00% | – |
| Q2 2018 | $39,000 | +5.4% | 28,000 | +53.6% | 0.00% | – |
| Q4 2017 | $37,000 | -98.7% | 18,228 | -98.2% | 0.00% | -100.0% |
| Q2 2017 | $2,905,000 | – | 1,015,834 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 169,901 | $411,000 | 0.03% |
| Benin Management CORP | 14,300 | $35,000 | 0.01% |
| Northeast Financial Consultants Inc | 15,000 | $36,000 | 0.01% |
| WEDBUSH SECURITIES INC | 25,500 | $62,000 | 0.01% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 49,167 | $119,000 | 0.00% |
| Renaissance Technologies | 344,299 | $833,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 8,238 | $20,000 | 0.00% |
| NORTHERN TRUST CORP | 47,859 | $116,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 28 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 146,083 | $353,000 | 0.00% |